Clinical Trial Update: Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the Emerge 1.20 mm PTCA dilatation catheter for enlarging the coronary luminal diameter in Coronary Artery Disease. Results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Emerge 1.20 mm PTCA Dilatation Catheter (PTCA dilatation catheter)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-11-06